Q1 2019 13F Holders as of 31 Mar 2019
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
226M
-
Number of holders
-
1060
-
Total 13F shares, excl. options
-
226M
-
Shares change
-
-2.27M
-
Total reported value, excl. options
-
$64.9B
-
Value change
-
-$572M
-
Put/Call ratio
-
0.73
-
Number of buys
-
478
-
Number of sells
-
-482
-
Price
-
$286.98
Significant Holders of Elevance Health, Inc. - Common Stock (ELV) as of Q1 2019
1,175 filings reported holding ELV - Elevance Health, Inc. - Common Stock as of Q1 2019.
Elevance Health, Inc. - Common Stock (ELV) has 1,060 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 226M shares
.
Largest 10 shareholders include BlackRock Inc. (22M shares), VANGUARD GROUP INC (19.3M shares), PRICE T ROWE ASSOCIATES INC /MD/ (19.3M shares), STATE STREET CORP (11.3M shares), FMR LLC (10.4M shares), WELLINGTON MANAGEMENT GROUP LLP (8.17M shares), Viking Global Investors LP (6.19M shares), BAILLIE GIFFORD & CO (4.43M shares), GEODE CAPITAL MANAGEMENT, LLC (3.63M shares), and Invesco Ltd. (3.46M shares).
This table shows the top 1060 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.